B. Riley Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.4M Buy
22,302
+208
+0.9% +$213K 1.47% 8
2026
Q1
$19.6M Sell
22,094
-3,093
-12% -$3.14M 1.24% 10
2025
Q4
$27.1M Sell
25,187
-2,217
-8% -$2.12M 1.25% 12
2025
Q3
$20.9M Buy
27,404
+949
+4% +$706K 0.97% 15
2025
Q2
$20.6M Buy
+26,455
New +$20.6M 0.97% 15
2024
Q4
$26.1M Sell
33,816
-3,491
-9% -$2.89M 0.86% 13
2024
Q3
$33M Sell
37,307
-923
-2% -$830K 0.92% 12
2024
Q2
$34.6M Sell
38,230
-4,848
-11% -$3.88M 0.88% 12
2024
Q1
$23.1M Buy
43,078
+2,973
+7% +$2.12M 0.63% 28
2023
Q4
$23.4M Sell
40,105
-2,973
-7% -$1.74M 0.63% 23
2023
Q3
$23.1M Buy
43,078
+936
+2% +$482K 0.63% 28
2023
Q2
$19.8M Sell
42,142
-3,558
-8% -$1.49M 0.44% 46
2023
Q1
$15.7M Buy
45,700
+6,027
+15% +$2.03M 0.42% 47
2022
Q4
$14.5M Buy
39,673
+4,083
+11% +$1.45M 0.41% 50
2022
Q3
$11.5M Buy
35,590
+13,203
+59% +$4.18M 0.35% 62
2022
Q2
$7.26M Buy
22,387
+1,419
+7% +$426K 0.31% 73
2022
Q1
$6M Sell
20,968
-2,532
-11% -$652K 0.2% 111
2021
Q4
$6.49M Buy
23,500
+405
+2% +$103K 0.19% 112
2021
Q3
$5.34M Sell
23,095
-239
-1% -$59K 0.17% 131
2021
Q2
$5.34M Sell
23,334
-12,758
-35% -$2.56M 0.17% 139
2021
Q1
$6.74M Buy
36,092
+18,676
+107% +$3.65M 0.24% 95
2020
Q4
$2.94M Sell
17,416
-11,030
-39% -$1.65M 0.16% 147
2020
Q3
$4.39M Buy
28,446
+13,196
+87% +$2.04M 0.23% 98
2020
Q2
$2.5M Sell
15,250
-861
-5% -$132K 0.17% 140
2020
Q1
$2.24M Sell
16,111
-394
-2% -$54.1K 0.19% 126
2019
Q4
$2.17M Buy
16,505
+2,275
+16% +$264K 0.18% 125
2019
Q3
$1.59M Buy
14,230
+1,398
+11% +$156K 0.16% 153
2019
Q2
$1.43M Sell
12,832
-585
-4% -$68.9K 0.16% 140
2019
Q1
$1.74M Buy
13,417
+172
+1% +$20.9K 0.22% 100
2018
Q4
$1.53M Buy
13,245
+1,517
+13% +$169K 0.22% 108
2018
Q3
$1.26M Sell
11,728
-360
-3% -$36K 0.15% 152
2018
Q2
$1.03M Buy
12,088
+24
+0.2% +$1.97K 0.14% 176
2018
Q1
$935K Sell
12,064
-10,825
-47% -$871K 0.13% 180
2017
Q4
$1.94M Sell
22,889
-1,181
-5% -$100K 0.26% 105
2017
Q3
$2.06M Sell
24,070
-490
-2% -$40.2K 0.34% 79
2017
Q2
$2.02M Sell
24,560
-1,500
-6% -$122K 0.37% 67
2017
Q1
$2.19M Sell
26,060
-765
-3% -$61.3K 0.44% 54
2016
Q4
$1.97M Sell
26,825
-5,002
-16% -$373K 0.4% 61
2016
Q3
$1.49M Sell
31,827
-233
-0.7% -$18.6K 0.29% 81
2016
Q2
$1.48M Sell
32,060
-319
-1% -$24K 0.3% 80
2016
Q1
$1.37M Buy
32,379
+2,774
+9% +$210K 0.32% 75
2015
Q4
$2.5M Buy
29,605
+11,281
+62% +$936K 0.51% 43
2015
Q3
$1.53M Buy
18,324
+245
+1% +$20.7K 0.37% 61
2015
Q2
$1.51M Sell
18,079
-60
-0.3% -$4.57K 0.38% 56
2015
Q1
$1.32M Sell
18,139
-16,385
-47% -$1.17M 0.32% 77
2014
Q4
$12.8K Buy
34,524
+11,585
+51% +$782K 0.27% 68
2014
Q3
$1.49M Sell
22,939
-20,259
-47% -$1.28M 0.39% 53
2014
Q2
$1.4M Buy
43,198
+21,892
+103% +$1.31M 0.33% 53
2014
Q1
$1.25M Sell
21,306
-5,098
-19% -$285K 0.38% 53
2013
Q4
$1.35M Sell
26,404
-6,695
-20% -$335K 0.43% 45
2013
Q3
$1.67M Buy
33,099
+3,212
+11% +$168K 0.57% 29
2013
Q2
$1.47M Buy
+29,887
New +$1.63M 0.5% 36

Other funds holding LLY

B. Riley Wealth Advisors's LLY Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Eli Lilly (LLY) stake by 0.94% in Q2 2026, buying an estimated $213K and bringing the position to 22,302 shares worth $27.4M. The position accounts for 1.47% of the portfolio, ranked #8.

B. Riley Wealth Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.6M in Q2 2024. 1,616 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • B. Riley Wealth Advisors held 22,302 shares of Eli Lilly worth $27.4M as of Q2 2026.
  • B. Riley Wealth Advisors bought 208 Eli Lilly shares in Q2 2026, an estimated $213K.
  • Eli Lilly made up 1.47% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #8 holding.
  • B. Riley Wealth Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's Eli Lilly position peaked at $34.6M in Q2 2024.
  • 1,616 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.